Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07086339 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema

Study acronym: IAB-3
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 2 sitesv4
  2. Phase: Phase 2 to Not applicablev3 Show 5 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Oct 2026 to Aug 2027
    • Start date changed from estimate of Sep 2025 to Feb 4, 2026
    • Study sites: 1 to 2
    • Study completion date: Nov 2027 to Dec 2027
  3. Study title revisedv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pulmair Medical, Inc.
3 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
A Study at Two Hospitals Testing the Safety and Effectiveness of the IAB 50 Flex, a New Implant for Adults with Severe COPD or Emphysema
Trial Details
NCT Number NCT07086339
Lead Sponsor Pulmair Medical, Inc.
Conditions
(from sponsor)		 COPD, Emphysema
Related terms Emphysema, Lung Diseases, Pulmonary Disease, Chronic Obstructive
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov